Catalyst Pharmaceutical CPRX Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiGainLoss.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Catalyst Pharmaceutical's net gains (losses) on investments?
- Catalyst Pharmaceutical (CPRX) reported net gains (losses) on investments of $4.75M in Q1 2026.
- How has Catalyst Pharmaceutical's net gains (losses) on investments changed year-over-year?
- Catalyst Pharmaceutical's net gains (losses) on investments increased by 79.7% year-over-year, from $2.64M to $4.75M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.